ONESOURCENSEOnesource Specialty Pharma LimitedMediumNeutral
Announced Thu, 12 Feb · 16:48 IST

Onesource Specialty Pharma Limited has informed the Exchange about ESG rating by SES ESG Research Private Limited

Business Updates View source PDF

ONESOURCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

OneSource Specialty Pharma has disclosed that SES ESG Research Private Limited has assigned it an ESG score of 65.7. The rating was received on February 11, 2026, and is based on FY 2024-25 data available in the public domain. Notably, the company did not commission or engage SES for this rating — it was independently prepared by SES using publicly available information. The company is sharing this with the exchanges as required under SEBI Listing Regulations.

Likely market impact

An ESG score of 65.7 is a moderate-to-good rating and may help the company attract ESG-focused institutional investors. Since the company did not seek this rating, the impact on stock price is likely limited but adds to its sustainability credentials.